Latest news
Loading news…
EvlaBio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Zürich, Zurich, Switzerland Founded 2022 1-10 employees For Profit
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
0
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 0
- Trademarks
- 2
- IT spend
- $256K
Company Info
- Founded
- 2022
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 8
- HQ
- Zürich, Zurich, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.5
- Trend (30d)
- -0.9
- Trend (90d)
- -1.4
- Last leadership hire
- Dec 7, 2025
Key People at EvlaBio
Chief Scientific Officer
1
professional contacts at EvlaBio
Contact execs at EvlaBio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to EvlaBio
Loading news…
FAQs about EvlaBio
People who checked this page also checked these
Browse the full Acquirezy directory.